Molson Coors Could Drop 3% as Barclays Cuts Target to $40
Barclays slashed Molson Coors' price target to $40, underscoring earnings headwinds as the brewer anticipates a tough...
Learn actionable strategies to identify and overcome budgeting pitfalls that hinder your financial health and create a sustainable plan.
22,245 articlesBarclays slashed Molson Coors' price target to $40, underscoring earnings headwinds as the brewer anticipates a tough...
Is intuitive surgical right now? The robotics leader faces macro headwinds and strong long term demand. This guide br...
Yara International’s chief executive outlines a relentless, all-out strategy to weather Middle East tensions, signali...
April brought a surprising surge for Tower Semiconductor, defying the notion that only the biggest chipmakers can mov...
OpenAI launches Daybreak to catch vulnerabilities before hackers exploit them, signaling a new era for crypto risk ma...
REZ steadies its footing as a mix of healthcare REITs and self-storage assets cushions exposure to a softening reside...
A potential 18-day walkout by 45,000 Samsung memory workers could disrupt DRAM and high-bandwidth memory supply, send...
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Two entertainment giants, Netflix and Disney, are navigating a fast-changing landscape. This analysis breaks down rec...
A biotech stock has surged 355%, catching the eye of every investor from day traders to pension funds. A prominent he...
When a major chip stock slips, it sparks questions about why the move happened and what it means for your plan. This ...
A major DeFi breach on the BNB Chain drains $7.3 million from over 1,400 liquidity providers linked to aging DxSale c...